Daily non-political popular news in brief.
Radiation and drug combo helps boost efficacy of lung cancer treatment
09-01-2007 · EurekAlert!Combining radiation therapy with a drug that helps destroy blood vessels nourishing malignant tumors has been shown in mice to be significantly more effective in treating lung cancer than either approach alone, researchers at UT Southwestern Medical Center have found.
Read more »
Keywords: radiation, drug, combo, boost, efficacy, lung, cancer, treatment
« Previous | Next »
Similar news on "Radiation and drug combo helps boost efficacy of lung cancer treatment":
- Radiation and drug combo helps boost efficacy of lung-cancer treatment
09-04-2007 · UT Southwestern Medical Center
Combining radiation therapy with a drug that helps destroy blood vessels nourishing malignant tumors has been shown in mice to be significantly more effective in treating lung cancer than either approach alone, researchers at UT Southwestern Medical Center have found.
Similar news · Read more »
- Radiation plus chemo quadruples survival time for fatal brain cancer
10-29-2007 · EurekAlert!
Over four times as many patients with a rapidly fatal type of brain cancer, glioblastoma multiforme, who are treated with the chemotherapy drug temozolomide and radiation therapy, can live for four years after diagnosis, compared to those who receive only radiation treatment, according to updated results of a large, international trial presented at the Plenary I session on Oct. 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Similar news · Read more »
- Normal tissue not spared in new forms of breast cancer radiotherapy
10-30-2007 · EurekAlert!
A five-day course of radiotherapy to treat breast cancer may, in some cases, expose as much lung and heart tissue to potentially toxic radiation as does the standard six weeks of treatment, say researchers at Mayo Clinic Jacksonville.
Similar news · Read more »
- Ireland Cancer Center researchers advance lung cancer treatment
04-23-2007 · EurekAlert!
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents, such as Tarceva (erlotinib). Using a new second-generation of Tarceva-like medications, researchers can overcome the drug resistance, and such drugs are now in development including in clinical trials at the Ireland Cancer Center.
Similar news · Read more »
- New cancer treatment adds to survival rates in lung cancer patients
06-28-2007 · EurekAlert!
Patients with inoperable non-small cell lung cancer who receive an initial high dose of chemotherapy before their treatment begins can expect an increase in overall survival, according to a study in the July 1 issue of the International Journal of Radiation Oncology, Biology, Physics, the official journal of ASTRO.
Similar news · Read more »
- PET scan shows during treatment if radiation is shrinking lung tumor, U-M study shows
07-18-2007 · EurekAlert!
Lung cancer patients may not need to wait till their radiation treatment is over to know if it worked. A PET scan several weeks after starting radiation treatment for lung cancer can indicate whether the tumor will respond to the treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.
Similar news · Read more »
- Extra radiation dose prevents breast cancer return in young women
10-29-2007 · EurekAlert!
Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation after undergoing breast-conserving surgery and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose.
Similar news · Read more »
- Tumor cells evade death through autophagy
01-18-2007 · EurekAlert!
Autophagy (a process that enables cells to turnover their contents) is initiated in tumor cells by chemotherapy and radiation, but it is not known if this causes tumor cell death or helps tumor cells survive. A new mouse study now indicates that autophagy is a survival mechanism for tumor cells treated with agents that initiate tumor cell death, suggesting that adjunct treatment with autophagy inhibitors might increase the efficacy of some chemotherapeutics in cancer patients.
Similar news · Read more »
- Jefferson researchers show chemotherapy and radiation together extend lung cancer patients' lives
11-09-2007 · EurekAlert!
Chemotherapy given at the same time as radiation therapy can help patients with a certain type of lung cancer live nearly 50 percent longer than they might have otherwise if the same treatment was given differently, according to an international team’s analysis of several trial results.
Similar news · Read more »
- Blood pressure drug shows potential as lung cancer treatment
03-15-2007 · EurekAlert!
A hormone that is important in the control of blood pressure also shrinks lung cancer tumors in mice, suggesting a new way to prevent or treat the deadly cancer, according to scientists at Wake Forest University School of Medicine.
Similar news · Read more »
